Markets.com Logo

IMNN

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    6.5069$
  • Previous Close
    6.5479$
  • 52 Week Change
    36.39$
  • Day Range
    -0.04$
  • 52 Week High/Low
    4.8261$ - 41.2174$
  • Dividend Per Share
    --
  • Market cap
    16 363 K$
  • EPS
    -2.15
  • Beta
    2.163
  • Volume
    --

About

IMNN.US represents ImmunoPrecise Antibodies Ltd., a biopharmaceutical company headquartered in Utrecht, Netherlands. It is a publicly traded company listed on the Nasdaq exchange under the symbol IMNN. The company is focused on the discovery and development of fully human antibodies for therapeutic and diagnostic applications. Their research and development efforts primarily target oncology, autoimmune, and infectious diseases.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Industry Trends: The overall health and performance of the immunotherapy industry significantly impacts investor sentiment towards IMNN. Positive clinical trial results from competitors or increased adoption of immunotherapy treatments can boost IMNN's stock, while setbacks in the field can negatively affect it. Company Performance: IMNN's financial results, including revenue growth, profitability, and cash flow, directly influence its stock price. Strong performance typically leads to increased investor confidence and a higher stock value. Clinical Trial Results: The success or failure of IMNN's clinical trials for its immunotherapy candidates is a major driver of its stock price. Positive trial data demonstrating efficacy and safety can lead to significant stock appreciation, while negative or inconclusive results can cause the stock to decline. Regulatory Approvals: The approval of IMNN's drugs by regulatory agencies like the FDA is a critical catalyst for stock price increases. Approval signifies market access and revenue potential. Market Sentiment: General investor sentiment and market conditions, such as economic growth or recession, can impact IMNN's stock price. A positive market environment tends to support growth stocks like IMNN, while a negative environment can lead to selling pressure. Competition: The competitive landscape within the immunotherapy market affects IMNN's prospects. The emergence of new competitors or more effective therapies from rivals can negatively impact IMNN's market share and stock price. Partnerships and Collaborations: Strategic partnerships and collaborations with other pharmaceutical companies or research institutions can boost IMNN's stock price. These collaborations often provide access to new technologies, resources, or markets. Management Team: The experience and reputation of IMNN's management team play a role in investor confidence. A strong and credible management team can instill trust and attract investors.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--